2001
DOI: 10.1530/rep.0.1210259
|View full text |Cite
|
Sign up to set email alerts
|

Effects of genistein on the periovulatory expression of messenger ribonucleic acid for matrix metalloproteinases and tissue inhibitors of metalloproteinases in the rat ovary

Abstract: The matrix metalloproteinases (MMPs) play critical roles in the ovulatory process. Their expression and activity, together with those of the endogenous tissue inhibitors of metalloproteinases (TIMPs), are stimulated by LH. The LH surge initiates a cascade of events resulting in ovulation and formation of the corpus luteum via activation of protein kinases A and C, as well as tyrosine kinases. In vitro perfused rat ovaries were untreated, or treated with LH (0.2 microg ml(-1)) plus 0.2 mmol 3-isobutyl-1-methylx… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 6 publications
(8 reference statements)
0
5
0
Order By: Relevance
“…Matrix metalloproteinase-9 was elevated in fluid of preovulatory follicles of pigs [95] and horses [96] and in formative corpora lutea or luteinized granulosa cells of rats [97], cattle [98,99], and human beings [100]. Collagenase-3 (MMP-13), which degrades collagens I-III, was increased in preovulatory rat follicles [101,102]. Cathepsin L (a lysosomal cysteine protease member of the papain family) and ADAMTS-1 (a disintegrin and metalloproteinase with thrombospondin-like motifs) were induced in preovulatory follicles of rodents; mice with a mutant progesterone receptor gene, which fail to ovulate, expressed MMP-2, -9, and -13 upon gonadotropic stimulation; however, mRNAs encoding cathepsin L and ADAMTS-1 were reduced [103].…”
Section: Additional Considerationsmentioning
confidence: 99%
“…Matrix metalloproteinase-9 was elevated in fluid of preovulatory follicles of pigs [95] and horses [96] and in formative corpora lutea or luteinized granulosa cells of rats [97], cattle [98,99], and human beings [100]. Collagenase-3 (MMP-13), which degrades collagens I-III, was increased in preovulatory rat follicles [101,102]. Cathepsin L (a lysosomal cysteine protease member of the papain family) and ADAMTS-1 (a disintegrin and metalloproteinase with thrombospondin-like motifs) were induced in preovulatory follicles of rodents; mice with a mutant progesterone receptor gene, which fail to ovulate, expressed MMP-2, -9, and -13 upon gonadotropic stimulation; however, mRNAs encoding cathepsin L and ADAMTS-1 were reduced [103].…”
Section: Additional Considerationsmentioning
confidence: 99%
“…Several genes have been characterized as downstream targets of RUNX1 in various hematopoietic cells, although the transcriptional regulation of RUNX1 on these genes was found to be cell-type specific (17). Among these genes, a few have been found to be up-regulated in periovulatory ovaries, such as cyclin-dependent kinase inhibitor 1A (cdkn1a) (18,19), tissue inhibitor of metalloproteinase-1 (Timp1) (20,21), and matrix metalloproteinase 13 (Mmp13) (22,23). Studies with promoter regions of RUNX1 target genes have demonstrated the importance of the cooperation of RUNX1 with other transcription factors in regulating gene expression (19).…”
mentioning
confidence: 99%
“…Protein tyrosine kinases appear to be critical in the signaling cascade initiated by BSG as treatment with genistein, a protein kinase inhibitor, ablated BSG-stimulated Mmp13 expression by cultured fibroblasts [40]. Genistein also inhibited Mmp13 expression by whole rat ovaries perfused in vitro with LH [41]; it therefore seems plausible that BSG could regulate ovarian MMP13 via a similar pathway to that described in tumor-stroma interactions. In human lung fibroblasts, BSG stimulated Mmp13 expression through the p38 signaling cascade, whereas induction of Mmp2 was mediated through the phospholipase A 2 /5-lipoxygenase catalyzed pathway in breast cancer cells [40,42].…”
Section: Discussionmentioning
confidence: 91%